Huntsman Cancer Institute researchers identify promising drug combination for melanoma ...Middle East

- News
Huntsman Cancer Institute researchers identify promising drug combination for melanoma
Researchers at Huntsman Cancer Institute at the University of Utah have identified a potential drug combination to treat uveal melanoma, a type of eye cancer. Lead author Amanda Truong, trainee in the McMahon Lab at HCI and student at the U of U, explains uveal melanoma patients frequently have changes in genes called GNAQ and GNA11, which are key targets for these drugs. This study was published in the journal Clinical Cancer Research.

Hence then, the article about huntsman cancer institute researchers identify promising drug combination for melanoma was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Huntsman Cancer Institute researchers identify promising drug combination for melanoma )

Apple Storegoogle play

Last updated :

Also on site :